A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
Clinical trial NCT00304525 · COMPLETED
Trial details
- NCT number
- NCT00304525
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2013-11-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.